Anti-HSD3B1 is intended for the semi-quantitative detection of Hydroxy-Delta-5-Steroid Dehydrogenase, 3 Beta-And Steroid Delta-Isomerase 1 (HSD3B1) in paraffin sections.
Immunogen:
HSD3B1 (AAH31999.1, 1 a.a. ~373 a.a.) full length recombinant protein with GST tag.
Host:
Mouse
Specificity:
Human Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
Isotype:
IgG1, kappa
Storage Buffer:
In 1x PBS, pH 7.2
Storage Instruction:
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Steroidogenic enzymes, their related transcription factors and nuclear receptors in human sebaceous glands under normal and pathological conditions.Azmahani A, Nakamura Y, Felizola SJ, Ozawa Y, Ise K, Inoue T, McNamara KM, Doi M, Okamura H, Zouboulis CC, Aiba S, Sasano H.J Steroid Biochem Mol Biol. 2014 Jul 29. pii: S0960-0760(14)00134-4. doi: 10.1016/j.jsbmb.2014.07.010.
2.
Gestational Trophoblastic Tumors and Related Tumor-Like Lesions.Shih IM, Mazur MT, Kurman RJ.Blaustein"s Pathology of the Female Genital Tract 2011, 1075-1135, DOI: 10.1007/978 -1-4419-0489-8_20
3.
Advances in the diagnosis of gestational trophoblastic tumors and tumor-like lesions.Mao TL, Shih IM.Expert Opin. Med. Diagn. (2009) 3(4):371-380
4.
Chorangiocarcinoma: A Case Report and Review of the Literature.Ariel I, Boldes R, Weintraub A, Reinus C, Beller U, Arbel R.Int J Gynecol Pathol. 2009 May;28(3):267-71.
5.
HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.Mao TL, Kurman RJ, Jeng YM, Huang W, Shih IM.Am J Surg Pathol. 2008 Feb;32(2):236-42.
6.
Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions.Shih IeM.Ann Diagn Pathol. 2007 Jun;11(3):228-34.
Immunohistochemical staining of various tissues with hematoxylin and HSD3B1 antibody under high magnification. [antibody concentration 3 ug/ml]( a ) Stomach( b ) Esophagus( c ) Endometrium( d ) Uterine cervix( e ) Placenta( f ) Ovary, clear cell carcinoma( g ) Hepatocellular carcinoma( h ) Breast cancer( i ) Colon adenocarcinoma ( j and k ) Cervical carcinoma( l, m, and n ) Choriocarcinoma( o ) Epithelioid trophoblastic tumor